Characteristics and challenges of the clinical pipeline of digital therapeutics

In this Comment, we characterize the current pipeline of digital therapeutics and offer a clinical perspective into the advantages, challenges, and barriers to implementation of this treatment modality for patient care, which we hope will inform future regulatory policy, prescribing decisions, and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Nisarg A., Butte, Atul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733514/
https://www.ncbi.nlm.nih.gov/pubmed/33311567
http://dx.doi.org/10.1038/s41746-020-00370-8
_version_ 1783622289001021440
author Patel, Nisarg A.
Butte, Atul J.
author_facet Patel, Nisarg A.
Butte, Atul J.
author_sort Patel, Nisarg A.
collection PubMed
description In this Comment, we characterize the current pipeline of digital therapeutics and offer a clinical perspective into the advantages, challenges, and barriers to implementation of this treatment modality for patient care, which we hope will inform future regulatory policy, prescribing decisions, and scope of real-world evidence collection.
format Online
Article
Text
id pubmed-7733514
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77335142020-12-17 Characteristics and challenges of the clinical pipeline of digital therapeutics Patel, Nisarg A. Butte, Atul J. NPJ Digit Med Comment In this Comment, we characterize the current pipeline of digital therapeutics and offer a clinical perspective into the advantages, challenges, and barriers to implementation of this treatment modality for patient care, which we hope will inform future regulatory policy, prescribing decisions, and scope of real-world evidence collection. Nature Publishing Group UK 2020-12-11 /pmc/articles/PMC7733514/ /pubmed/33311567 http://dx.doi.org/10.1038/s41746-020-00370-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Comment
Patel, Nisarg A.
Butte, Atul J.
Characteristics and challenges of the clinical pipeline of digital therapeutics
title Characteristics and challenges of the clinical pipeline of digital therapeutics
title_full Characteristics and challenges of the clinical pipeline of digital therapeutics
title_fullStr Characteristics and challenges of the clinical pipeline of digital therapeutics
title_full_unstemmed Characteristics and challenges of the clinical pipeline of digital therapeutics
title_short Characteristics and challenges of the clinical pipeline of digital therapeutics
title_sort characteristics and challenges of the clinical pipeline of digital therapeutics
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733514/
https://www.ncbi.nlm.nih.gov/pubmed/33311567
http://dx.doi.org/10.1038/s41746-020-00370-8
work_keys_str_mv AT patelnisarga characteristicsandchallengesoftheclinicalpipelineofdigitaltherapeutics
AT butteatulj characteristicsandchallengesoftheclinicalpipelineofdigitaltherapeutics

Ejemplares similares